Brief: Conmed Q3 Adjusted EPS USD 1.08 Vs. IBES Estimate USD 1.05
05/11/2025 21:05
Nov 05 (Reuters) - Conmed Q3 sales USD 337.926 million vs. IBES estimate USD 334.8 million. Q3 income from operations USD 11.879 million Q3 net income USD 2.859 million Q3 pretax profit USD 4.273 million Q3 EPS USD 0.09 outlook FY revenue USD 1,365-1,372 million outlook FY adjusted EPS USD 4.48-4.53
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED